M. Edip Gurol MD, MScVascular Neurologist and Director, High Hemorrhage Risk Stroke Prevention Clinic, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Dr. Gurol, a vascular neurologist and researcher at Massachusetts General Hospital and Harvard Medical School, is an international expert on ischemic and hemorrhagic stroke prevention as well as cerebral small vessel diseases of the elderly such as cerebral amyloid angiopathy. These conditions increase the risk of both hemorrhagic and ischemic cerebral events in affected individuals and they are major contributors to cognitive impairment. Dr. Gurol uses advanced neuroimaging techniques to clarify the molecular and physiologic mechanisms of these brain microangiopathies and develop methods to stratify stroke risk. Dr. Gurol leads the High Hemorrhage Risk Stroke Prevention Clinic with a focus on stroke prevention in the high-risk patient, i.e. patients with a hemorrhage prone cerebral pathology and a concomitant high embolic risk such as atrial fibrillation. Dr. Gurol published about 200 scientific articles and he gave invited talks at more than 100 national and international scientific meetings. He is the PI of the multicenter Neuro-AFib study, an observational study aimed at understanding the mechanisms of ischemic and hemorrhagic strokes in patients with atrial fibrillation as well as other mechanistic studies on cerebral small vessel diseases. He is the Neurocardiology Section Editor of American Heart Association’s Stroke journal and the chair of the World Stroke Organization’s global taskforce on Cerebral Small Vessel Diseases and Vascular Cognitive Impairment.
Dr. Gurol is supported by NIH grants as well as research grants to Massachusetts General Hospital from industry (AVID, Pfizer, Boston Scientific).